Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Willis Towers Watson PLC a un objectif de cours consensus de $325.7, basé sur les évaluations des 23 analystes. Le plus élevé est de $400 attribué par Raymond James le décembre 5, 2024, et le plus bas est de $257 attribué par Baird le mai 1, 2023. Les 3 dernières évaluations d'analystes ont été publiées par Morgan Stanley, Citigroup et Wells Fargo le août 18, 2025, août 13, 2025 et juillet 10, 2025. Avec un objectif de cours moyen de $355 entre Morgan Stanley, Citigroup et Wells Fargo, il y a une variation implicite de 7.55% upside pour Willis Towers Watson PLC à partir de ces dernières évaluations d'analystes.
1calculé à partir des notes des analystes
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
08/18/2025 | 4.52% | Morgan Stanley | $335 → $345 | Maintains | Equal-Weight | |||
08/13/2025 | 6.34% | Citigroup | → $351 | Initiates | → Neutral | |||
07/10/2025 | 11.79% | Wells Fargo | $387 → $369 | Maintains | Overweight | |||
07/07/2025 | -7.6% | Barclays | $316 → $305 | Maintains | Underweight | |||
04/28/2025 | 10.89% | Keefe, Bruyette & Woods | $371 → $366 | Maintains | Outperform | |||
04/11/2025 | -4.26% | Barclays | $302 → $316 | Maintains | Underweight | |||
04/11/2025 | 12.4% | Jefferies | $373 → $371 | Maintains | Buy | |||
04/09/2025 | — | Keefe, Bruyette & Woods | — | Maintains | Outperform | |||
03/18/2025 | 19.67% | UBS | $344 → $395 | Upgrade | Neutral → Buy | |||
02/10/2025 | 13.01% | Jefferies | $382 → $373 | Maintains | Buy | |||
01/14/2025 | 4.52% | Wells Fargo | $380 → $345 | Maintains | Overweight | |||
01/10/2025 | 17.25% | Keefe, Bruyette & Woods | $378 → $387 | Maintains | Outperform | |||
12/05/2024 | 21.19% | Raymond James | $365 → $400 | Upgrade | Outperform → Strong Buy | |||
12/04/2024 | 15.13% | Truist Securities | $365 → $380 | Reiterates | Buy → Buy | |||
12/04/2024 | 14.52% | Keefe, Bruyette & Woods | $359 → $378 | Maintains | Outperform | |||
11/21/2024 | -8.5% | Barclays | $278 → $302 | Maintains | Underweight | |||
11/05/2024 | 8.76% | Keefe, Bruyette & Woods | $352 → $359 | Maintains | Outperform | |||
11/04/2024 | 3.01% | Wells Fargo | $334 → $340 | Maintains | Overweight | |||
10/09/2024 | -4.87% | Jefferies | $295 → $314 | Maintains | Hold | |||
10/03/2024 | 1.19% | Wells Fargo | $321 → $334 | Maintains | Overweight | |||
10/02/2024 | 4.52% | Roth MKM | $315 → $345 | Maintains | Buy | |||
10/02/2024 | 10.58% | Truist Securities | $335 → $365 | Maintains | Buy | |||
09/04/2024 | -15.78% | Barclays | → $278 | Initiates | → Underweight | |||
07/31/2024 | -2.14% | Keefe, Bruyette & Woods | $320 → $323 | Maintains | Outperform | |||
07/26/2024 | -4.57% | Roth MKM | $300 → $315 | Maintains | Buy | |||
07/26/2024 | 1.49% | Truist Securities | $310 → $335 | Maintains | Buy | |||
07/26/2024 | -2.75% | Wells Fargo | $318 → $321 | Maintains | Overweight | |||
07/10/2024 | -17.59% | Morgan Stanley | $275 → $272 | Maintains | Equal-Weight | |||
06/20/2024 | -3.66% | Wells Fargo | $317 → $318 | Maintains | Overweight | |||
05/22/2024 | -7.9% | B of A Securities | $272 → $304 | Upgrade | Underperform → Neutral | |||
05/06/2024 | -5.78% | Keefe, Bruyette & Woods | $317 → $311 | Maintains | Outperform | |||
04/29/2024 | -5.47% | Citigroup | $315 → $312 | Maintains | Buy | |||
04/26/2024 | -10.63% | Evercore ISI Group | — | $290 → $295 | Maintains | In-Line | ||
04/26/2024 | -8.2% | Piper Sandler | $297 → $303 | Maintains | Overweight | |||
04/11/2024 | -3.66% | Wells Fargo | $320 → $318 | Maintains | Overweight | |||
04/10/2024 | -3.96% | Keefe, Bruyette & Woods | $307 → $317 | Maintains | Outperform | |||
03/28/2024 | -4.57% | Raymond James | $295 → $315 | Reiterates | Outperform → Outperform | |||
02/13/2024 | -4.57% | Citigroup | $236 → $315 | Upgrade | Neutral → Buy | |||
02/12/2024 | -9.72% | BMO Capital | → $298 | Upgrade | Underperform → Market Perform | |||
02/12/2024 | -4.57% | Citigroup | $236 → $315 | Upgrade | Neutral → Buy | |||
02/07/2024 | -18.81% | Stifel | $236 → $268 | Maintains | Hold | |||
02/07/2024 | -6.08% | Truist Securities | $275 → $310 | Maintains | Buy | |||
02/07/2024 | -18.2% | Morgan Stanley | $248 → $270 | Maintains | Equal-Weight | |||
02/07/2024 | -9.11% | Roth MKM | $275 → $300 | Maintains | Buy | |||
02/07/2024 | -3.05% | Wells Fargo | $288 → $320 | Maintains | Overweight | |||
01/11/2024 | -12.75% | Wells Fargo | $248 → $288 | Upgrade | Equal-Weight → Overweight | |||
01/10/2024 | -4.26% | TD Cowen | → $316 | Initiates | → Outperform | |||
10/31/2023 | -22.74% | Raymond James | $250 → $255 | Maintains | Outperform | |||
10/27/2023 | -19.11% | Piper Sandler | $265 → $267 | Maintains | Overweight | |||
10/27/2023 | -16.68% | Truist Securities | $265 → $275 | Maintains | Buy | |||
10/27/2023 | -28.5% | Morgan Stanley | $225 → $236 | Maintains | Equal-Weight | |||
10/11/2023 | -31.83% | Morgan Stanley | $245 → $225 | Maintains | Equal-Weight | |||
10/06/2023 | -31.53% | Jefferies | $218 → $226 | Maintains | Hold | |||
09/19/2023 | -32.44% | Citigroup | $221 → $223 | Maintains | Neutral | |||
09/13/2023 | -19.71% | Piper Sandler | $270 → $265 | Maintains | Overweight | |||
08/28/2023 | -24.26% | Roth MKM | $285 → $250 | Maintains | Buy | |||
08/09/2023 | -33.04% | Citigroup | $251 → $221 | Maintains | Neutral | |||
08/08/2023 | -37.89% | BMO Capital | $230 → $205 | Downgrade | Market Perform → Underperform | |||
07/31/2023 | -24.26% | Raymond James | $260 → $250 | Maintains | Outperform | |||
07/28/2023 | -21.23% | Raymond James | $270 → $260 | Downgrade | Strong Buy → Outperform | |||
07/27/2023 | -21.23% | Raymond James | → $260 | Downgrade | Strong Buy → Outperform | |||
07/17/2023 | -26.38% | Wells Fargo | $249 → $243 | Maintains | Equal-Weight | |||
06/20/2023 | -23.96% | Morgan Stanley | → $251 | Initiates | → Equal-Weight | |||
05/23/2023 | -30.32% | BMO Capital | $260 → $230 | Maintains | Market Perform | |||
05/02/2023 | -23.96% | Citigroup | $256 → $251 | Maintains | Neutral | |||
05/01/2023 | -13.65% | Keefe, Bruyette & Woods | $289 → $285 | Maintains | Outperform | |||
05/01/2023 | -22.14% | Baird | $259 → $257 | Maintains | Outperform | |||
04/28/2023 | -18.2% | Raymond James | $275 → $270 | Maintains | Strong Buy | |||
04/28/2023 | -24.56% | Wells Fargo | $255 → $249 | Maintains | Equal-Weight | |||
04/18/2023 | -12.44% | Keefe, Bruyette & Woods | $303 → $289 | Maintains | Outperform | |||
04/18/2023 | -22.44% | Citigroup | $255 → $256 | Maintains | Neutral | |||
04/10/2023 | -30.32% | Jefferies | $235 → $230 | Maintains | Hold | |||
02/27/2023 | -12.14% | Goldman Sachs | → $290 | Upgrade | Neutral → Buy | |||
02/16/2023 | -21.53% | Baird | $246 → $259 | Maintains | Outperform | |||
02/14/2023 | -22.74% | Stifel | $228 → $255 | Maintains | Hold | |||
01/20/2023 | -21.23% | BMO Capital | → $260 | Initiates | → Market Perform | |||
01/18/2023 | -22.74% | Wells Fargo | $218 → $255 | Maintains | Equal-Weight | |||
01/18/2023 | -8.2% | Keefe, Bruyette & Woods | → $303 | Upgrade | Market Perform → Outperform | |||
01/17/2023 | -15.17% | Piper Sandler | $250 → $280 | Maintains | Overweight | |||
01/09/2023 | -17.9% | Goldman Sachs | $229 → $271 | Maintains | Neutral | |||
12/29/2022 | -15.17% | Raymond James | $250 → $280 | Maintains | Strong Buy | |||
12/15/2022 | -8.5% | Credit Suisse | $288 → $302 | Maintains | Outperform | |||
12/15/2022 | -25.17% | Citigroup | → $247 | Initiates | → Neutral | |||
12/05/2022 | -13.65% | MKM Partners | $250 → $285 | Maintains | Buy | |||
11/22/2022 | -27.29% | Morgan Stanley | $242 → $240 | Maintains | Equal-Weight | |||
10/28/2022 | -33.95% | Wells Fargo | $220 → $218 | Maintains | Equal-Weight | |||
10/13/2022 | -24.26% | Piper Sandler | → $250 | Upgrade | Neutral → Overweight | |||
10/12/2022 | -40.32% | B of A Securities | $210 → $197 | Maintains | Underperform | |||
09/28/2022 | -33.35% | Wells Fargo | → $220 | Maintains | Equal-Weight | |||
09/26/2022 | -12.75% | Credit Suisse | → $288 | Initiates | → Outperform |
Le dernier objectif de prix pour Willis Towers Watson (NASDAQ:WTW) a été rapporté par Morgan Stanley le août 18, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $345.00 s'attendant à ce que WTW se rise dans les 12 prochains mois (un possible changement de 4.52% upside). 23 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
La dernière note d'analyste pour Willis Towers Watson (NASDAQ:WTW) a été fournie par Morgan Stanley, et Willis Towers Watson maintenu leur note equal-weight.
La dernière amélioration pour Willis Towers Watson PLC a eu lieu le mars 18, 2025 lorsque UBS a augmenté leur objectif de prix à $395. UBS avait précédemment a neutral pour Willis Towers Watson PLC.
La dernière réduction pour Willis Towers Watson PLC a eu lieu le août 8, 2023 lorsque BMO Capital a changé leur objectif de prix de $230 à $205 pour Willis Towers Watson PLC.
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de Willis Towers Watson, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour Willis Towers Watson a été déposée le août 18, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers août 18, 2026.
Bien que les évaluations soient subjectives et changeront, la dernière note de Willis Towers Watson (WTW) était un maintenu avec un objectif de prix de $335.00 à $345.00. Le prix actuel de Willis Towers Watson (WTW) est de $330.07, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.